FF
PPH icon

Fluent Financial’s VanEck Pharmaceutical ETF PPH Stock Holding History

Fluent Financial’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.26M Buy
+38,992
New +$4.04M 1.52% 18
2025
Q2 		– Sell
-16,923
Closed -$1.54M – 71
2025
Q1 		$1.54M Buy
+16,923
New +$1.52M 0.67% 35

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return
AWC
Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Fluent Financial's PPH Position: Q2 2026 in Review

Fluent Financial opened a new position in VanEck Pharmaceutical ETF (PPH) in Q2 2026: 38,992 shares worth $4.26M. The stake represents 1.52% of the portfolio and ranks #18 among its holdings. This is a return to the name: Fluent Financial previously reported a position in PPH as recently as Q1 2025.

Fluent Financial first reported a position in PPH in Q1 2025 and has held it in 2 quarters since. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

  • Fluent Financial held 38,992 shares of VanEck Pharmaceutical ETF worth $4.26M as of Q2 2026.
  • VanEck Pharmaceutical ETF was a new Fluent Financial position in Q2 2026.
  • VanEck Pharmaceutical ETF made up 1.52% of Fluent Financial's portfolio in Q2 2026, its #18 holding.
  • Fluent Financial first reported a position in VanEck Pharmaceutical ETF in Q1 2025 and has held it in 2 quarters since.
  • 148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Fluent Financial's 13F filing for Q2 2026, filed 9 Jul 2026.